Biblio Discovery — Demo Discovery Service

7 results for "Humaira Zafar"

Showing 1–7 · 0.10 seconds · RSS

  1. Journal Article Full text

    Fucosyltransferase 2 inhibitors: Identification via docking and STD-NMR studies

    Humaira Zafar; Muhammad Atif; Atia-tul-Wahab et al.

    PLOS ONE, Vol. 16 No. 10 · 2021 · English · PLOS Scopus

    Fucosyltransferase 2 (FUT2) catalyzes the biosynthesis of A, B, and H antigens and other important glycans, such as (Sialyl Lewisx) sLex, and (Sialyl Lewisy) sLey. The production of these glycans is increased in various cancers, hence to design and develop specific inhibitors of FUT2 is a…

  2. Journal Article Full text

    Drug repurposing against fucosyltransferase-2 via docking, STD-NMR, and molecular dynamic simulation studies

    Muhammad Atif; Humaira Zafar; Atia-tul- Wahab et al.

    PLOS ONE, Vol. 19 No. 11 · 2024 · English · PLOS Scopus

    Aberrant fucosylation is the hallmark of malignant cell transformation, leading to many cellular events, such as uncontrolled cell proliferation, angiogenesis, tumor cell invasion, and metastasis. This increased fucosylation is caused due to the over-expression of fucosyltransferases (FUTs) that…

  3. Journal Article Full text

    Structural transformation of a hydrogel-forming cell division protein ZapB of multidrug resistant Klebsiella pneumoniae with small molecules

    Ayesha Khan; M. Iqbal Choudhary; Sumaira Javaid et al.

    PLOS One, Vol. 21 No. 4 · 2026 · English · PLOS Scopus

    Septal ring assembly protein ZapB (EMR18431.1) is involved in Z-ring formation, and nucleoid segregation during the bacterial cell division . It promotes cell division in the initial stages of the cell cycle through direct interaction with FtsZ, thus stimulating Z-ring assembly. The ZapB inhibition…

  4. Journal Article Full text

    Identification of new fucosyltransferase-8 inhibitors: An integrated biochemical, biophysical, and computational approach

    Muhammad Awais; Noor Rahman; Sumaira Javaid et al.

    PLOS One, Vol. 21 No. 10 · 2026 · English · PLOS Scopus

    The α-1,6-fucosyltransferase (FUT8) mediated core fucosylation is responsible for several pathophysiological processes, including prostate cancer progression. FUT8 is a promising therapeutic target owing to its effects on cell migration and its capacity to convert androgen-dependent prostate cancer…

  5. Journal Article Full text

    Thymidine phosphorylase and prostrate cancer cell proliferation inhibitory activities of synthetic 4-hydroxybenzohydrazides: In vitro , kinetic, and in silico studies

    Sumaira Javaid; Syed Muhammad Saad; Humaira Zafar et al.

    PLOS ONE, Vol. 15 No. 1 · 2020 · English · PLOS Scopus

    Over-expression of thymidine phosphorylase (TP) plays a key role in many pathological complications, including angiogenesis which leads to cancer cells proliferation. Thus in search of new anticancer agents, a series of 4-hydroxybenzohydrazides (1–29) was synthesized, and evaluated for in vitro…

  6. Journal Article Full text

    Anti-leishmanial physalins—Phytochemical investigation, in vitro evaluation against clinical and MIL-resistant L . tropica strains and in silico studies

    Saira Bano; Memoona Bibi; Saba Farooq et al.

    PLOS ONE, Vol. 17 No. 11 · 2022 · English · PLOS Scopus

    Cutaneous leishmaniasis (CL) is a major health problem in over 98 countries of the world, including Pakistan. The current treatments are associated with a number of adverse effects and availability problem of drugs. Therefore, there is an urgent need of easily available and cost effective…

  7. Journal Article Full text

    Antipsychotics drug aripiprazole as a lead against breast cancer cell line (MCF-7) in vitro

    Adnan Badran; Atia tul-Wahab; Humaira Zafar et al.

    PLOS ONE, Vol. 15 No. 8 · 2020 · English · PLOS Scopus

    Breast cancer is the second leading cause of death among women globally. The existing treatment options for breast cancer are largely associated with severe toxicities, and lower efficacies. Therefore, there is an urgent need for the development of non-toxic effective drugs against breast cancer…